Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04852783 · ClinicalTrials.gov registry record · Phase 4
US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair
A Phase 4 study of Aneurysm, Intracranial, sponsored by Cerus Endovascular.
- Active
- Registry status
- Phase 4
- Development phase
- 250
- Enrollment target
- 20
- Study locations
NCT04852783 is a Phase 4 study of Aneurysm, Intracranial that is active but no longer recruiting, run by Cerus Endovascular. The registered enrollment target is 250 participants, above the 215-participant average among 3 other Aneurysm, Intracranial trials with a reported enrollment target (16% higher). The trial reports 20 study locations across 12 states.
The verdict
NCT04852783, a Phase 4 study of Aneurysm, Intracranial, is active but no longer recruiting, sponsored by Cerus Endovascular.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 250 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.
Conditions Studied
Interventions
- DEVICE Contour Neurovascular System
Study Locations (20)
New York
- University at Buffalo Neurosurgery - Buffalo
- NYU Langone Health - New York
- Stony Brook Medicine - Stony Brook
- Montefiore Medical Center - The Bronx
- Westchester Medical Center - Valhalla
Pennsylvania
- The Hospital of the University of Pennsylvania - Philadelphia
- Thomas Jefferson University - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Illinois
- University of Chicago - Chicago
- Advocate Aurora Health - Park Ridge
Massachusetts
- Massachusetts General Hospital - Boston
- UMASS Medical Center - Worcester
Colorado
- Swedish Medical Center - Englewood
Florida
- Baptist Health - Jacksonville
Kansas
- University of Kansas Medical Center - Kansas City
North Carolina
- NC Heart and Vascular Research LLC - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2030-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04852783
The ClinicalTrials.gov registry entry for NCT04852783 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 215-participant average among 3 other Aneurysm, Intracranial trials with a reported enrollment target (16% higher). The listed sponsor is Cerus Endovascular, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aneurysm, Intracranial appearing as the primary indexed condition, and to 1 intervention - of which Contour Neurovascular System is the first listed.
NCT04852783 reports 20 study locations spanning 12 distinct geographic areas - top geographies include New York, Pennsylvania, Illinois.
Frequently Asked Questions
What is clinical trial NCT04852783 about?
NCT04852783 is a clinical study titled "US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair". The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.
What is the current status of trial NCT04852783?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2021-08-06. Estimated completion is 2030-02.
What conditions does trial NCT04852783 study?
This clinical trial studies the following conditions: Aneurysm, Intracranial.
What interventions are being tested in trial NCT04852783?
The interventions under investigation include: Contour Neurovascular System (DEVICE).
Who is sponsoring clinical trial NCT04852783?
This trial is sponsored by Cerus Endovascular, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04852783 being conducted?
This trial has 20 study locations across Colorado, Florida, Illinois, Kansas, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aneurysm, Intracranial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
RECRUITING · NA
-
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
RECRUITING · NA
-
Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.